CA
NZ
UK
AU
IND
US
● CalciMedica is pivoting toward pulmonary hypertension after discontinuing lead drug Auxora in a Phase 2 acute kidney injury trial following a safety signal.
● aTyr Pharma cut its workforce by roughly 60% on August 7, 2026, reducing annualized operating expenses by about $13 million starting in the fourth quarter.
Capricor Therapeutics, Inc. (NASDAQ:CAPR), the San Diego-based clinical-stage biotechnology company developing cell and exosome-based therapies for rare diseases, saw its shares climb 62.59% this week to close at $6.65. The advance follows a dramatic reset in expectations: shares had collapsed roughly 70% in late …
Omeros Corporation (NASDAQ:OMER) shares advanced sharply this week, rising 30.72% to close at $17.19, though the stock pulled back 0.92% on Friday's close after a large portion of the week's gains came in a single post-earnings surge on Wednesday. The Seattle based commercial stage …
Clinical stage biotechnology companies frequently trade on binary catalysts, and AbCelleraBiologicsInc. (NASDAQ:ABCL) offered a clear illustration this week, with shares rising 64.21% to close at $11.38. The company's lead pipeline asset, ABCL635, is an antibody designed to treat moderate to severe vasomotor symptoms tied …
Eton Pharmaceuticals, Inc. (NASDAQ:ETON), the Deer Park, Illinois-based specialty pharmaceutical company focused on developing and commercializing treatments for rare and underserved diseases, saw its shares climb 31.97% this week to close at $58.86. The advance followed second-quarter results released August 14 that set company …
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) shares rose 20.92% over the week to close at $22.72, even though the stock declined 1.77% on Friday, its finalTrading sessionof the period. The San Diego based medical device company, known for its t:slim X2 and Tandem Mobi insulin …
Astrana Health, Inc. (NASDAQ:ASTH), the Alhambra, California-based physician-centric, technology-powered healthcare management company, saw its shares climb 14.12% this week to close at $40.81. The advance followed second-quarter results released August 14 that showed net income more than doubling year over year, alongside a raised …
Faeth Therapeutics, Inc. (NASDAQ:FTH) shares advanced sharply this week, rising 32.11% to close at $32.34, including a single day gain of 13.28% at Friday's close. The clinical stage oncology company, which rebranded from Sensei Biotherapeutics in mid 2026 following its acquisition of Faeth Holdings …
Varex Imaging Corporation (NASDAQ:VREX), the Salt Lake City-based designer and manufacturer of X-ray imaging components and the world's largest independent supplier of medical X-ray tubes and image processing solutions, saw its shares climb 48.99% this week to close at $18.49. The advance traces almost …
Please wait processing your request...